Inhibition of the pacemaker current: A bradycardic therapy for off-pump coronary operations

Annals of Thoracic Surgery

Volumn 66, Issue 1, 1998, Pages 148-152

  Bel, Alain ^a,b   Perrault, Louis P ^a,b   Faris, Bouchaib ^a,b   Mouas, Christian ^a,b   Vilaine, Jean Paul ^a,b   Menasché, Philippe ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; ESMOLOL; IVABRADINE; NICORANDIL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ACTIVITY; EXPERIMENTAL SURGERY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HEART RATE; HEART SURGERY; ISOLATED HEART; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; RABBIT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; BRADYCARDIA; CARDIAC OUTPUT; CARDIAC VOLUME; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; DIASTOLE; HEART ARREST, INDUCED; HEART RATE; MYOCARDIAL CONTRACTION; NIACINAMIDE; NICORANDIL; POTASSIUM; POTASSIUM CHANNELS; PROPANOLAMINES; RABBITS; SINOATRIAL NODE; STEREOISOMERISM; VENTRICULAR FUNCTION, LEFT;

EID: 17144460372     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00346-4     Document Type: Article

References (23)

1. 1. Sweeney MS, Frazier OH. Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg 1992;54:1065-70.
2. 2. Pirk J, Kellovsky P. An alternative to cardioplegia. Ann Thorac Surg 1995;60:464-5.
3. 3. Lönn U, Peterzen B, Granfeldt H, Casimir-Ahn H. Coronary artery operation with support of the Hemopump cardiac assist system. Ann Thorac Surg 1994;58:519-23.
4. 4. Ede M, Ye J, Gregorash L, et al. Beyond hyperkalemia: β-blocker-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg 1997;63:721-7.
5. 5. Qiu Y, Galinanes M, Hearse DJ. Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia. J Thorac Cardiovasc Surg 1995;110:1063-72.
6. + cardioplegia. Int J Cardiol 1995;48: 11-25.
7. 7. Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 1994;112: 37-42.
8. 8. Bois P, Bescond J, Renaudon B, Lenfant J. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial cells. Br J Pharmacol 1996;118:1051-7.
9. 9. Jansen EWL, Grundeman PF, Borst C, et al. Less invasive off-pump CABG using a suction device for immobilization: the "Octopus" method. Eur J Cardiothorac Surg 1997;12: 406-12.
10. 10. Boonstra P, Grandjean GJ, Mariani MA. Improved method for direct coronary grafting without CPB via anterolateral small thoracotomy. Ann Thorac Surg 1997;63:567-9.
11. 11. Brodde OJ. β adrenoreceptors. In: Williams M, Glennon RA, Timmermans PBMWM, eds. Receptor pharmacology and function. New York: Marcel Dekker, 1989:207-43.
12. 1-adrenergic mechanism. Circ Res 1993; 73:656-70.
13. 13. Cohen NM, Wise RM, Wechsler AS, Damiano RJ. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection? J Thorac Cardiovasc Surg 1993;106: 317-28.
14. 14. Mitani A, Kinoshita K, Fukamachi K, et al. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Am J Physiol 1991;261:H1864-71.
15. 15. Jovanovic A, Alekseev AE, Lopez JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg 1997;63:153-61.
16. 16. Grover GJ, Sleph PG, Parham CS. Nicorandil improves postischemic contractile function independently of direct myocardial effects. J Cardiovasc Pharmacol 1990;15:698-705.
17. 17. Simon L, Ghaleh B, Puybasset L, Giudicelli JF, Berdeaux A. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995;275:659-66.
18. 18. Gardiner SM, Kemp PA, March JE, Bennett T. Acute and chronic cardiac and regional hemodynamic effects of the novel bradycardic agent, S 16257, in conscious rats. Br J Pharmacol 1995;115:579-86.
19. 19. Thollon C, Bidouard JP, Cambarrat C, et al. Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257. Eur J Pharmacol 1997;339:43-51.
20. 20. Nataf P, Lima L, Benarim S, et al. Video-assisted coronary bypass surgery: clinical results. Eur J Cardiothorac Surg 1997;11:865-9.
21. 21. De Jong JW, van der Meer P, van Loon H, Owen P, Opie LH. Adenosine as adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. J Thorac Cardiovasc Surg 1990;100:445-54.
22. 22. Robinson MC, Thielmeier KA, Hill BB. Transient ventricular asystole using adenosine during minimally invasive and open sternotomy coronary artery bypass grafting. Ann Thorac Surg 1997;63:S30-4.
23. 1 adenosine receptors in rabbit heart. Circulation 1990;84:350-6.